Hookworms are becoming resistant to treatment—what now?December 22, 2022Hookworm cases are on the rise, not just in the South, where warm and humid conditions provide a perfect environment for them. In 2018, the prevalence of hookworms (Ancylostoma caninum) was just four percent in dogs across the country. Three years prior, it was only two percent, meaning, it had risen by almost 50 percent in that period.
SPONSORED CONTENTA new way to offer multi-organ supportNEW Hill's Prescription Diet Multi-Organ offers therapeutic nutrition for pets that may have conflicting nutritional needs. + Learn More
Augusta-Richmond, Ga., ranked top hookworm city for JulyAugust 18, 2020Augusta-Richmond, Ga., is the number one city for hookworm in July, the Companion Animal Parasite Council (CAPC) reports.
Hookworm stubbornly persists across U.S.July 16, 2020Rockford, Ill., is the number one city for hookworm in June, the Companion Animal Parasite Council (CAPC) reports.
Pharma group's $400M deal finalizedJuly 6, 2020Merck Animal Health has completed the acquisition of Virbac’s proprietary Sentinel flavor tabs and Sentinel Spectrum chews, which protect companion animals from common internal parasites, including heartworms, roundworms, and hookworms.
Hookworm rampant across U.S.June 24, 2020Des Moines, Iowa, is the number one city for hookworm in May, the Companion Animal Parasite Council (CAPC) reports.
Pharma group rounds out parasite protections in $400M dealMay 14, 2020Merck Animal Health’s acquisition of Virbac’s proprietary products expands the company’s offerings of internal parasite preventatives.
New guidelines help ensure heartworm safety, prevention amid COVID-19April 7, 2020Conditions under which a veterinarian can delay annual heartworm tests during the COVID crisis is just one of the topics covered in new recommendations released by AHS.
Boehringer declares war on wormsFebruary 18, 2020Following the success of its Heartworm 2020 initiative, which saw 58,800 previously unprotected dogs receive heartworm disease prevention, Boehringer Ingelheim has upped the ante for 2021.
